Strong expression association between matriptase and its substrate prostasin in breast cancer.
about
Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survivalGene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotypeType II transmembrane serine protease gene variants associate with breast cancer.Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.Prostasin: An Epithelial Sodium Channel Regulator.Dysregulated lipid metabolism in cancer.Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.The fat side of prostate cancer.α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.The role of type II transmembrane serine protease-mediated signaling in cancer.Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.Regulation of matriptase and HAI-1 system, a novel therapeutic target in human endometrial cancer cells.Activated matriptase as a target to treat breast cancer with a drug conjugate.Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation.
P2860
Q27314964-216101A5-BA03-416A-AB24-63B23E20D2D4Q28539811-40F0ED88-BC25-41FA-8560-7B54C36E51F1Q33910850-9EECF9FF-205C-46C7-87A8-A55ABBA86710Q34854941-6F83413B-BBF4-494B-81B8-CD62AAAC58DCQ35622091-34653D3F-878F-4C21-9512-39CA57153DF6Q36198689-B0A5FDBE-D5BD-4C22-8AB4-B7957DB1F5EBQ36567735-4E24FC11-9B4E-42C9-B832-D1C4184AFD3DQ36967340-C8DA27E0-0513-4B57-9C59-95D63955CFF1Q37629000-02897709-1FCD-4A0D-868F-52ACF3A0279EQ38096735-967589A8-9D88-46FA-8EEF-8A19BD80A49EQ38793227-0D6FF9AC-3E65-447E-A844-E42B9799A388Q39015415-35C8542E-C8C8-4B26-AB11-191B0D9DA7A0Q39626361-EBB7C015-85E5-4978-AF79-E342809F5D20Q52645865-BB891EA4-9F5B-4407-969D-78F8C5E402A5Q55054374-A630697C-D371-4BDB-87A2-A9FAF55E3969Q55515387-AD7C5FFA-1EED-4A4B-B9E0-C07641CEDE85
P2860
Strong expression association between matriptase and its substrate prostasin in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Strong expression association ...... te prostasin in breast cancer.
@en
Strong expression association ...... te prostasin in breast cancer.
@nl
type
label
Strong expression association ...... te prostasin in breast cancer.
@en
Strong expression association ...... te prostasin in breast cancer.
@nl
prefLabel
Strong expression association ...... te prostasin in breast cancer.
@en
Strong expression association ...... te prostasin in breast cancer.
@nl
P2093
P2860
P356
P1476
Strong expression association ...... te prostasin in breast cancer.
@en
P2093
Christopher Bergum
Gina Zoratti
Julie Boerner
Karin List
P2860
P304
P356
10.1002/JCP.22877
P577
2012-04-01T00:00:00Z